Back to today’s briefing

Story perspectives

U.S. Faces Severe Flu Season: 24 Million Infected

2/22/2025

50 11

Summary

Story summary

The U.S. is grappling with a harsh flu season, reporting 24 million cases and 13,000 tragic deaths. While Tamiflu can alleviate symptoms for high-risk individuals, other antivirals like Relenza, Rapivab, and Xofluza also offer hope. However, these medications require a prescription and may come with side effects, emphasizing the need for cautious use.

1 of 1

Story summary

The U.S. is grappling with a harsh flu season, reporting 24 million cases and 13,000 tragic deaths. While Tamiflu can alleviate symptoms for high-risk individuals, other antivirals like Relenza, Rapivab, and Xofluza also offer hope. However, these medications require a prescription and may come with side effects, emphasizing the need for cautious use.